Compounded Tirzepatide & NAD+ Metabolic Stack

The stack is two separately compounded, physician-prescribed injectables shipped together: one vial of compounded tirzepatide for appetite and blood-sugar control, and one vial of NAD+ for cellular energy and recovery. There is a single formulation of each — no dosage tiers to pick from. Your physician provides the per-injection instructions for both.

Tirzepatide works on your gut-brain signalling to reduce hunger and slow digestion, which drives the weight loss. NAD+ works inside your cells, powering mitochondrial energy production and repair. Weight loss drains cellular energy; NAD+ replenishes it. One controls intake, the other sustains output.

Yes, under medical supervision. The two act on completely different pathways (hormone receptors vs. cellular coenzyme metabolism) and have no known direct interaction. Both are prescribed together only after a licensed physician reviews your health history.

Separately. They are two different vials and two different injections, each given subcutaneously (belly, thigh, or upper arm). Many patients do both on the same day; your physician will confirm the schedule that suits you.

Both are typically weekly injections. Your physician provides exact per-dose instructions for the tirzepatide and the NAD+ based on your assessment. There is no escalation schedule to manage.

Reduced calorie intake, rapid weight loss, and shifts in blood sugar all put your cells in an energy deficit, and NAD+ levels — which already decline with age — fall further under caloric restriction. That cellular shortfall is a major driver of fatigue and brain fog on tirzepatide, which is exactly what NAD+ is added to address.

Most patients notice reduced appetite within 1–2 weeks and improved energy and focus from NAD+ within 2–4 weeks. Meaningful weight loss builds over 3–6 months; clinical trials of tirzepatide show average losses of 15–22% of body weight over 15–18 months.

Up to 25–40% of weight lost on tirzepatide can be lean mass if nothing is done to protect it. NAD+ supports the energy and recovery you need to keep training, and combined with adequate protein and resistance exercise, helps more of your loss come from fat.

Tirzepatide: nausea, constipation, or mild GI discomfort, most common in the first weeks and usually easing over time. NAD+: brief flushing, warmth, or mild injection-site tenderness. Serious side effects are rare; your physician reviews warnings with you before prescribing.

No. Both medications are compounded by a licensed U.S. pharmacy and are not FDA-approved; the FDA does not evaluate compounded drugs for safety, effectiveness, or quality. FDA-approved tirzepatide medications (Zepbound, Mounjaro) are available by prescription. Discuss the risks and benefits with your physician.

Anyone who is pregnant, breastfeeding, or planning pregnancy; anyone with a personal or family history of medullary thyroid carcinoma or MEN2; and anyone with a history of pancreatitis or severe gastrointestinal disease. Your physician screens for these during your assessment.

Tirzepatide slows digestion, which can affect timing and absorption of some oral medications, and may require adjustments if you take insulin or sulfonylureas. NAD+ has no well-documented drug interactions. Tell your physician about everything you take, including supplements.

Keep both vials refrigerated at 36-46°F (2-8°C), protected from light, and never frozen. Follow the in-use guidance that ships with your order.

Appetite typically returns within a few weeks of stopping tirzepatide, and energy benefits from NAD+ fade gradually as cellular levels decline again. Patients who maintain protein intake, resistance training, and sleep habits built during treatment are most likely to keep their results. Your physician can help you plan a taper.

Tirzepatide alone controls hunger but does nothing for the energy, focus, and muscle you lose along the way. Oral NMN/NR supplements are largely broken down in digestion and have no weight-loss action. Injectable NAD+ delivers the full dose directly, and pairing it with tirzepatide covers both halves of a sustainable transformation.